Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Choosing wisely in complementary treatment for cancer in the Philippines

Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital...

Choosing wisely in complementary treatment for cancer in the Philippines ( Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines )

Indications for the appropriate use of a PET-CT scan for common cancers

Dr Jonas Santiago - St Luke's Medical Center, Manila, Philippines

Indications for the appropriate use of a PET-CT scan for common cancers ( Dr Jonas Santiago - St Luke's Medical Center, Manila, Philippines )

Choosing Wisely in neoadjuvant treatment for different cancers in the...

Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines

Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines ( Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines )

A multidisciplinary team approach to cancer care in the Philippines

Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines

A multidisciplinary team approach to cancer care in the Philippines ( Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines )

Choosing the right serum and molecular biomarkers in the Philippines

Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines

Choosing the right serum and molecular biomarkers in the Philippines ( Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines )

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR...

Prof Nicolas Girard - Institut Curie, Paris, France

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical...

Prof Nicolas Girard - Institut Curie, Paris, France

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical benefit in patients with resectable NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Four chemo cycles given with durvalumab and tremelimumab optimise response and...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

LUMINANCE: Results support use of durvalumab and platinum-etoposide for...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for...

Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC ( Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA )

Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1...

Dr Margarita Majem Tarruella - Hospital de la Santa Creu i Sant Pau, Barcelona...

Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC ( Dr Margarita Majem Tarruella - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )

Neo-adjuvant therapy for different cancers in the Philippines

Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines

Neo-adjuvant therapy for different cancers in the Philippines ( Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines )

More from ecancer